WASHINGTON (dpa-AFX) - After gapping open sharply lower, shares of Akorn (AKRX) continue to see substantial weakness in late-day trading on Tuesday. Akorn is currently down by 38.3 percent after hitting its lowest intraday level in a year.
The initial sell-off by Akorn came as a FDA probe of possible data breaches at the generic drugmaker has raised doubts about Fresenius' deal to acquire the company.
Copyright RTT News/dpa-AFX